Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Haley

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Journal for Immunotherapy of Cancer|December 2, 2014
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similaritiesMagdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cellsEdwin B Walker, Daniel Haley, William Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Journal for Immunotherapy of Cancer|December 2, 2014
Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similaritiesMagdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cellsEdwin B Walker, Daniel Haley, William Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Pageof 3